United States · FDA National Drug Code directory

Mesalamine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
42291-489_485f7bde-a4c9-b05b-e063-6394a90a34cf
Product NDC
42291-489
Form
TABLET, DELAYED RELEASE
Composition / generic term
Mesalamine
Labeler
AvKARE
Marketing category
ANDA
Marketing start / end (source format)
20240925
Source listing expiry
20271231

Source-listed ingredients

  • MESALAMINE — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 180 TABLET, DELAYED RELEASE in 1 BOTTLE (42291-489-18) · 42291-489-18

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →